Skip to main content
. 2022 Jan 18;14(3):405. doi: 10.3390/nu14030405

Table 5.

Changes in the lipid profile at 6 weeks after treatments by categories of variables according to the median value at baseline.

Intervention
Variable ABG Placebo Change Intertreatments
Baseline Change P for Trend Baseline Change P for Trend Mean (95% CI) p-Value
Total cholesterol, mg/dL
Global 243 ± 32 0.865
(−4.1; −5.9)
0.047 240 ± 30 2.15
(−3.1; 7.4)
0.421 * −1.29
(−8.6; 6.0)
0.727
≤242 mg/dL 219 ± 19 5.52
(−1.3; 12)
0.028 218 ± 22 6.90
(−1.9; 18)
0.120 * 0.914
(−8.7; 10)
0.849
>242 mg/dL 267 ± 24 −3.94
(−11; 3.4)
0.283 * 263 ± 21 −0.329
(−8.6; 8.0)
0.872 −3.49
(−7.7; 15)
0.535
LDLd, mg/dL
Global 165 ± 24 −0.390
(−4.1; 3.3)
0.011 165 ± 22 0.560
(−4.8; 3.7)
0.279 0.156
(−5.8; 5.5)
0.956
≤166 mg/dL 151 ± 14 3.33
(−1.1; 7.6)
0.143 * 147 ± 19 0.718
(−4.7; 6.1)
0.131 2.69
(−9.6; 4.2)
0.438
>166 mg/dL 188 ± 17 −8.20
(−15; −1.6)
0.017 *
0.014
182 ± 18 −2.55
(−9.8; 4.7)
0.475 −6.28
(−16; 3.1)
0.184
LDL (Friedewald), mg/dL
Global 162 ± 26 1.47
(−2.7; 5.6)
0.049 161 ± 25 1.91
(−3.3; 7.2)
0.308 −0.258
(−6.6; 7.1)
0.941
≤162 mg/dL 148± 17 4.50
(−0.41; 9.41)
0.071 * 148 ± 19 4.11
(−2.6; 11)
0.221 * 0.729
(−7.9; 9.3)
0.866
>162 mg/dL 186 ± 18 −3.79
(−11; 3.7)
0.063 184 ± 17 −1.99
(−11; 6.9)
0.607 −1.85
(−13; 9.5)
0.744
HDL, mg/dL
Global 56.9 ± 11.4 0.005
(−0.99; 1.0)
0.354 55.0 ± 10.9 1.02
(−0.41; 2.5)
0.159 * −0.695
(−2.5; 1.1)
0.492
≤55.5 mg/dL 49.3 ± 7.86 −0.045
(−1.4; 1.3)
0.136 48.2 ± 7.23 1.01
(−0.90; 2.9)
0.124 −1.49
(−3.7; 0.70)
0.178
>55.5 mg/dL 65.3 ± 8.32 0.061
(−1.4; 1.6)
0.816 62.8 ± 9.19 1.04
(−1.2; 3.3)
0.360 * 0.105
(−2.9; 3.1)
0.945
Total Cholesterol/ HDL
Global 4.41 ± 0.92 0.006
(−0.09; 0.10)
0.008 4.48 ± 0.82 −0.023
(−0.16; 0.12)
0.239 0.033
(−0.13; 0.20)
0.694
≤4.44 3.73 ± 0.45 0.062
(−0.03; 0.16)
0.200 * 3.86 ± 0.51 −0.022
(−0.22; 0.18)
0.358 0.074
(−0.15; 0.29)
0.506
>4.44 5.10 ± 0.74 −0.052
(−0.22; 0.12)
0.004 5.06 ± 0.60 −0.024
(−0.23; 0.18)
0.443 −0.023
(−0.30; 0.25)
0.864
LDLd/HDL
Global 3.02 ± 0.72 −0.013
(−0.08; 0.05)
0.001 3.09 ± 0.64 −0.049
(−0.15; 0.05)
0.168 0.156
(−5.8; 5.5)
0.956
≤3.07 2.47 ± 0.33 0.065
(−0.01; 0.14)
0.105 * 2.60 ± 0.41 −0.120
(−0.25; 0.07)
0.062 * 0.077
(−0.09; 0.24)
0.362
>3.07 3.58 ± 0.58 −0.114
(−0.24; 0.01)
0.071 *
0.002
3.55 ± 0.46 0.019
(−0.14; 0.18)
0.356 −0.05
(−0.21; 0.16)
0.782
LDL(Fried)/HDL
Global 2.95 ± 0.72 0.038
(−0.04; 0.12)
0.002 3.00 ± 0.63 0.001
(−0.11; 0.11)
0.089 0.041
(−0.09; 0.18)
0.551
≤2.94 2.43 ± 0.40 0.072
(−0.01; 0.15)
0.084 2.52 ± 0.41 −0.036
(−0.19; 0.12)
0.154 0.089
(−0.09; 0.27)
0.319
>2.94 3.49 ± 0.56 −0.021
(−0.15; 0.11)
0.002
3.45 ± 0.45 0.035
(−0.14; 0.21)
0.280 −0.021
(−0.22; 0.18)
0.840
TG (log), mg/dL
Global 2.04 ± 0.18 −0.031
(−0.06; − 0.001)
0.042 * 2.05 ± 0.19 −0.016
(−0.05; 0.02)
0.419 * −0.016
(−0.03; 0.06)
0.531
≤2.00 1.90 ± 0.09 −0.011
(−0.05; 0.03)
0.568 * 1.91 ± 0.09 0.024
(−0.04; 0.09)
0.438 * −0.021
(−0.10; 0.06)
0.603
>2.00 2.16 ± 0.15 −0.049
(−0.09; −0.002)
0.040 * 2.15 ± 0.13 −0.037
(−0.08; 0.07)
0.095 * −0.019
(−0.05; 0.09)
0.578
Log (TG/HDL)
Global 0.30 ± 0.23 −0.033
(−0.06; −0.001)
0.046 * 0.31 ± 0.23 −0.023
(−0.07; 0.02)
0.309 * −0.020
(−0.07; 0.04)
0.640
≤0.24 0.12 ± 0.11 −0.010
(−0.05; 0.03)
0.613 * 0.14 ± 0.12 0.009
(−0.06; 0.08)
0.789 * −0.020
(−0.10; 0.06)
0.610
≤0.24 0.47 ± 0.17 −0.055
(−0.11; −0.003)
0.038 * 0.49 ± 0.17 −0.055
(−0.12; 0.006)
0.073 * −0.004
(−0.08; 0.07)
0.909

ABG, aged black garlic; change, change from baseline; w, weeks; LDL, low-density lipoproteins; d, directly measured; fried, calculated by Friedewald formula; HDL, high-density lipoproteins; TGs, triglycerides. Data are expressed as the mean ± standard deviation or the mean (95% Confidence Interval, CI). Intra-treatment comparison by general linear model. P for: * quadratic trend; linear trend;  p < 0.05 vs. the baseline. Intertreatment comparisons by ANCOVA model adjusted by age, sex, and order.